Effects of treatment and the metabolic response to injury on drug clearance: a prospective study with piperacillin

Crit Care Med. 1990 Jan;18(1):37-41. doi: 10.1097/00003246-199001000-00010.

Abstract

The disposition of piperacillin was prospectively evaluated in 11 critically ill surgical patients who had no evidence of pre-existing renal and hepatic disease. Interpatient variations were demonstrated in the drug's half-life, distribution volume, and clearance, with values of 1.50 +/- 2.05 (SD) h, 25.0 +/- 17.2 L, and 23.8 +/- 17.2 L/h, respectively. Variations in piperacillin disposition were best explained by serum concentrations of albumin, total protein, and bilirubin, and the amount of urea nitrogen excreted daily in urine. Age and renal function were moderately associated with piperacillin elimination rate and clearance. Altered piperacillin disposition thus appeared to occur as secondary to changes in the patients' physiologic and metabolic state caused by injury-related stress and fluid/colloid therapy. These alterations may necessitate dosage modifications to achieve optimal patient response when treating patients with piperacillin as well as with other similar drugs eliminated via renal and nonrenal routes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aminoglycosides
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / blood
  • Drug Therapy, Combination / therapeutic use
  • Female
  • Half-Life
  • Humans
  • Inactivation, Metabolic
  • Male
  • Middle Aged
  • Piperacillin / administration & dosage
  • Piperacillin / pharmacokinetics*
  • Prospective Studies
  • Sepsis / drug therapy
  • Sepsis / metabolism*
  • Sepsis / therapy

Substances

  • Aminoglycosides
  • Anti-Bacterial Agents
  • Piperacillin